App-Quantinova.ai

Outcome of Glucose Homeostasis in Patients with Glucocorticoid-Induced Osteoporosis Undergoing Treatment with Bone Active-Drugs

Gherardo Mazziotti - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetes

Glucocorticoid

Vertebral Marrow Fat Is Not Associated with Bone Mass in Type 2 Diabetes Mellitus

Francisco J A de Paula - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

Glucocorticoid

Fetuin-a Levels in Patients with Primary Hyperparathyroidism

Nese Ersoz Gulcelik - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Primary hyperparathyroidism

Alkaline phosphatase

Efficacy of Vitamin D on Glucose Homeostasis in Obese Adolescents

Preneet Cheema Brar - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Vitamin D deficiency

Alkaline phosphatase

Vitamin D Supplementation Improves Glycaemia in Vitamin D Deficient Nigerians with Diabetes Mellitus

Anthony Chinedu Anyanwu - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

cholecalciferol

Severe Hyperlipidemia As an Indicator of Possible Familial Lipid Disorders - Its Associated Metabolic Derangements and Cardiovascular Risk Factors (RF) in Riga East Clinical University Hospital (RECUH): 3 Years Retrospective Study in Latvia

Linda Kucane - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Hypercholesterolemia, Familial, 1

N/A

Resolution of Insulin Requirement in Acquired Partial Lipodystrophy Related to Graft-Versus-Host Disease

Leslie Mae Kimura - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Acute lymphoblastic leukemia

Fenofibrate

Prevalence and Predictors of Diabetes after Lung Transplant - a Prospective, Longitudinal Study

Kathryn Lisa Hackman - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Prediabetes

N/A

Effects on Glycemic Control and Weight of a Widely Available Weight Control Program Tailored for People with Type 2 Diabetes: Six-Month Results

Patrick O,Neil - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

N/A

Gender Gap for LDL-C Goal Achievement Amongst Patients with Diabetes and Dyslipidemia

Pendar Farahani - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Dyslipidemia

N/A

Diabetes Does Not Negatively Influence on Overall Survival of Lung Cancer

Jung Min Kim - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal Cancer

Metformin Hydrochloride

A Study of Correlation of Metabolic and Hormonal Parameters with Sexual Dysfunction in Males with Type 2 Diabetes Mellitus in India

Ramesh Jayanthy - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

Mofezolac

The Effect of Early-Short Term Basal Insulin Treatment on Adiponectin Levels in Patients with Type 2 Diabetes Mellitus

Ugur nluetuerk - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

Insulin detemir

Primary Unresponsiveness to Pioglitazone Is Not Related to PPAR-Gamma and Its Co- Activator Gene SNP Polymorphs

Sandeep Kumar Mathur - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

Pioglitazone

Longitudinal Changes in CX3CL1 Targeting Micrornas in Patients with T2DM

Nalini Santanam - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

miR-16

Analysis of the Efficacy of U-500 Regular Insulin in Patients with Type 2 Diabetes and Insulin Resistance

Walaa Ayoub - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

Insulin regular

Association of Hypoglycemia with Different Oral Antidiabetic Treatments and Its Impact on Quality of Life and Disease Control in Patients with Type 2 Diabetes Mellitus (the HYPO study)

Grigorios Rombopoulos - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

sulfonylureas

Use of Insulin Pump Therapy in Patients with Type 2 Diabetes after Failure of Multiple Daily Injections. 4 Year Follow up

Shervin Yousefian - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

N/A

Safety and Efficacy of Empagliflozin Monotherapy in a 52-Week Study in Japanese Patients with Type 2 Diabetes Mellitus

Takashi Kadowaki - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

BI-10773

Linagliptin Monotherapy Versus Initial Combination Therapy with Metformin in Patients with Newly Diagnosed Type 2 Diabetes (T2D): A Randomized Controlled Trial

Maximilian von Eynatten - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

Linagliptin

Filters

4759 Abstracts